Latham & Watkins

Jane Lee

Deals
4
Latest
Aug 2026

Firm

Deals by year
Jane Lee: deals by year0123420252026 YTD: 4 M&A42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Jane Lee was named on, most recent first
Aug 2026 global rights for MT-7117 (dersimelagon) Tanabe PharmaLEO PharmaAsset saleLegal adviser to LEO Pharma (acquirer)Completed435.0Pharma+2LEO Pharma acquisition of global rights for MT-7117 (dersimelagon)
Jun 2026 Kiavi KiaviFigure Technology SolutionsAsset saleLegal adviser to Figure (acquirer)Announced717.0Fintech+2Figure Technology Solutions acquisition of Kiavi
May 2026 Replay –LEO PharmaAcquisitionLegal adviser to LEO Pharma (acquirer)Announced50.0Biotech+2LEO Pharma acquisition of Replay
Feb 2026 Highspot ––MergerLegal adviser to Seismic and PermiraCompleted–Software+2Seismic and Highspot merger

Deals where Jane Lee is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.